Skip to main content
Guidance

Guidance

Antiretroviral Agents
Care for People with HIV Displaced by Disasters
Contraception for HIV High-Risk or Infected Women

HIV/AIDS Clinical Guidelines

  • HIV/AIDS Clinical Guidelines
    (U.S. Department of Health and Human Services)
    These federally approved medical practice guidelines for HIV/AIDS are developed and updated by panels of HIV care experts. Following are selected USDHHS guidelines of interest. 
HIV Self-Testing Program Implementation and Data Reporting
  • Guidance for HIV Self-Testing Program Implementation and Data Reporting
    (Michigan Department of Health and Human Services, rev. February 2022)
    This document provides guidance on the creation of policies and procedures for program implementation and data entry for the HIV rapid self-administered over-the-counter (OTC) test (HIVST or rapid HIV self-test). This guidance is intended for use by programs funded or otherwise supported by MDHHS.
HIV/STI Minor Consent Guidance
  • HIV/STI Minor Consent Guidance
    (Michigan Department of Health and Human Services, October 2023)
    Local health departments and the clinical community are often used by minors (i.e., persons under the age of 18) to obtain testing and treatment for sexually transmitted infections (STIs) and HIV. There are emerging services sought by minors for the prevention and treatment for HIV/STIs that are not directly addressed by the law, which was traditionally written for bacterial STIs. This guidance document is for providers to use with their legal counsel to interpret how they may apply these laws to test and treat minors for HIV/STIs.
Opportunistic Infections
Perinatal
  • Guidelines for Testing and Reporting: Perinatal Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C, and Syphilis
    (Michigan Department of Health and Human Services, rev. February 2024)
    Physicians and other health care professionals providing medical treatment to birthing people are required, at the time of initial prenatal screening and examination, and during the third trimester, and at delivery in absence of previous testing results to test for HIV, hepatitis B, hepatitis C, and syphilis, unless the birthing person refuses to be tested or the provider deems the tests are medically inadvisable. These guidelines are for healthcare professionals working in prenatal care, labor and delivery, and emergency services.
Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis Guidelines (HIV)
  • PEP (Post-Exposure Prophylaxis)
  • PrEP (Pre-Exposure Prophylaxis)
Prevention
Primary Care Guidance for People with HIV
  • Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update
    (HIV Medicine Association of the Infectious Diseases Society of America, 2020)
    This evidence-based guidance for the primary care of people with human immunodeficiency virus (HIV) is intended for use by healthcare providers who care for people with HIV. Every 12 to 18 months following publication, IDSA reviews its guidelines to determine whether an update is required. This guidance was published in November of 2020 as an update to the 2013 guidelines.
Sexually Transmitted Infection Program Management and Evaluation Tools
Sexually Transmitted Infections Treatment Guidelines
  • 2021 Sexually Transmitted Infections Treatment Guidelines
    (Centers for Disease Control and Prevention)
    Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. The new guidelines include notable updates from the previous 2015 guidance, including:
    • updated treatment recommendations for chlamydia, trichomoniasis, and pelvic inflammatory disease;
    • updated treatment recommendations for uncomplicated gonorrhea in neonates, children, and other specific clinical situations (e.g., proctitis, epididymitis, sexual assault), which builds on broader treatment changes published in Morbidity and Mortality Weekly Report;
    • information on FDA-cleared diagnostic tests for Mycoplasma genitalium and rectal and pharyngeal chlamydia and gonorrhea;
    • expanded risk factors for syphilis testing among pregnant patients;
    • recommended two-step serologic testing for diagnosing genital herpes simplex virus;
    • harmonized recommendations for human papillomavirus vaccination with the Advisory Committee on Immunization Practices; and
    • recommended universal hepatitis C testing in alignment with CDC's 2020 hepatitis C testing recommendations.
Testing